BeyondSpring BYSI
NASDAQ BYSI
$0.77 +0.16 (+25.70%)
At close: Sep 10, 2026 · 4:00 PM EDT

BeyondSpring (BYSI) Divestments (2025)

BeyondSpring's (BYSI) quarterly Divestments came in at $7.4 million in Q1 2025.

Analysis

BeyondSpring (BYSI) Divestments (2025) Analysis & Trends

BeyondSpring has disclosed Divestments across 1 years of filings, most recently posting $7.4 million for Q1 2025.

  • In Q1 2025, Divestments changed N/A year-over-year to $7.4 million; the TTM figure through Dec 2025 stood at $7.4 million (changed N/A YoY), while the FY2025 annual figure was $7.4 million, changed N/A from the prior year.
  • Divestments came in at $7.4 million for Q1 2025 at BeyondSpring.
  • In the past five years, Divestments ranged from a high of $7.4 million in Q1 2025 to a low of $7.4 million in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn -
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn -
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn -
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn 62.00 Mn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn 1.88 Bn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn -
7 Revolution Medicines 42.88 Bn 42.88 Bn - -
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn -
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn -
10 BeyondSpring 31.51 Mn 31.51 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 7.35 Mn